Canopy Growth Corporation (CGC)
NASDAQ: CGC · Real-Time Price · USD
1.050
-0.020 (-1.87%)
At close: Nov 19, 2025, 4:00 PM EST
1.090
+0.040 (3.81%)
Pre-market: Nov 20, 2025, 8:38 AM EST
Canopy Growth Employees
Canopy Growth had 960 employees as of March 31, 2025. The number of employees decreased by 69 or -6.71% compared to the previous year.
Employees
960
Change (1Y)
-69
Growth (1Y)
-6.71%
Revenue / Employee
$208,357
Profits / Employee
-$288,556
Market Cap
360.57M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 960 | -69 | -6.71% |
| Mar 31, 2024 | 1,029 | -592 | -36.52% |
| Mar 31, 2023 | 1,621 | -1,530 | -48.56% |
| Mar 31, 2022 | 3,151 | -108 | -3.31% |
| Mar 31, 2021 | 3,259 | -1,175 | -26.50% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CGC News
- 1 day ago - Three Canadian Cannabis Stocks Worth Watching This Week - MarijuanaStocks
- 2 days ago - Canopy Growth Expands Spectrum Therapeutics Portfolio in Australia with New Softgels - Business Wire
- 4 days ago - Investing in Cannabis: Three Leading Stocks to Watch This November - MarijuanaStocks
- 7 days ago - Cannabis Investing Insight: Here Is How To Invest In Marijuana Stocks - MarijuanaStocks
- 8 days ago - Canopy Growth Q2 Results - Improved Net Loss, But Risks Remain - Seeking Alpha
- 12 days ago - Canopy Growth Corporation (WEED:CA) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Canopy Growth Reports Second Quarter Fiscal 2026 Financial Results; Company Continues to Strengthen Financial Performance with Improving Adjusted EBITDA, Disciplined Cost Management, and a Stronger Balance Sheet - Business Wire
- 19 days ago - 'Trump effect' raises hopes for cannabis rally as investors bet on federal reforms, softer marijuana stance - CNBC